BioSpace News Archive

FDA

Arthrosurface receives FDA Clearance of Patellofemoral WaveKahuna Arthroplasty System

Arthrosurface, Inc. announces their recent FDA 510(k) Clearance to market the Patellofemoral (PF) WaveKahuna Arthroplasty System.

June 29, 2018
·
2 min read
FDA

FDA Approves Zephyr Endobronchial Valve for Treating Severe Emphysema

Pulmonx® Corp. announced today that the U.S. Food and Drug Administration (FDA) has approved the Zephyr® Endobronchial Valve System.

June 29, 2018
·
4 min read
Deals

SensorRx To Acquire Groundbreaking Mobile Health App “Migraine Coach™"

Mobile Migraine App Shake-Up Announced Amid American Headache Society Scientific Meeting

June 29, 2018
·
2 min read
Business

Enzychem Lifesciences’ Growth Continues in US, Adds Jeff Clark as New Chief Licensing Officer

Enzychem Lifesciences Corp. hired Jeff Clark, MD, JD, a physician and patent attorney, as its Chief Licensing Officer.

June 29, 2018
·
3 min read
MEDISCA Signs Exclusive Distribution Agreement for FLAVORx Flavours in the Canadian Market

Customized Medication Flavouring Improves Patient Compliance

June 29, 2018
·
2 min read
Business

Enzychem Lifesciences held Launch Ceremony in USA

Enzychem Lifesciences held an opening ceremony of its US entity at Lotte New York Palace Hotel in New York City.

June 29, 2018
·
3 min read
Jazz Pharmaceuticals Enters Into Agreement with TerSera Therapeutics LLC for Prialt

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced a definitive agreement to sell its rights related to Prialt® (ziconotide) intrathecal infusion to TerSera Therapeutics LLC (TerSera).

June 29, 2018
·
5 min read
Pharm Country

Ajay Singh of Slayback Pharma wins Ernst and Young’s Entrepreneur Of The Year® 2018 Award in Life Sciences Category in New Jersey

Slayback Pharma today announced that Founder & CEO, Ajay Singh, of Slayback Pharma LLC is the winner of the 32nd Ernst and Young’s Entrepreneur Of The Year® 2018 Award in the Life Sciences category in New Jersey.

June 29, 2018
·
1 min read
Deals

Aralez Announces Voting Results From 2018 Annual Meeting Of Shareholders

Aralez Pharmaceuticals Inc. announced the results of the matters voted upon at the Company’s 2018 annual meeting of the shareholders of the Company held earlier today, which included the election of directors, as described below.

June 29, 2018
·
2 min read
Policy

Aralez Enters Into Amendment To Second Amended And Restated Facility Agreement

Aralez Pharmaceuticals Inc. announced that, in connection with its review of strategic alternatives, it entered into an Amendment to that certain Second Amended and Restated Facility Agreement

June 29, 2018
·
4 min read